Cargando…
CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma
Introduction: Squamous cell carcinoma (SCC) is the most common skin cancer with a high rate of death. Different lymphocyte populations play an important role in modulating the immune response in the tumor microenvironment. The increase in the proportion of cluster of differentiation (CD)4+ CD25+ reg...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597358/ https://www.ncbi.nlm.nih.gov/pubmed/34609428 http://dx.doi.org/10.47162/RJME.62.1.25 |
_version_ | 1784600587772362752 |
---|---|
author | Paşcalău, Andrei Vasile Cheregi, Cornel Dragoş Mureşan, Mihai Ştefan Şandor, Mircea Ioan Huniadi, Carmen Anca Nikin, Zoran Judea Pusta, Claudia Teodora Bodog, Florian Dorel Ionescu, Călin Pop, Ovidiu Laurean |
author_facet | Paşcalău, Andrei Vasile Cheregi, Cornel Dragoş Mureşan, Mihai Ştefan Şandor, Mircea Ioan Huniadi, Carmen Anca Nikin, Zoran Judea Pusta, Claudia Teodora Bodog, Florian Dorel Ionescu, Călin Pop, Ovidiu Laurean |
author_sort | Paşcalău, Andrei Vasile |
collection | PubMed |
description | Introduction: Squamous cell carcinoma (SCC) is the most common skin cancer with a high rate of death. Different lymphocyte populations play an important role in modulating the immune response in the tumor microenvironment. The increase in the proportion of cluster of differentiation (CD)4+ CD25+ regulatory T-cell (Treg) lymphocytes is associated, in different studies, with the increase of the cell multiplication rate. Aim: To analyze the Treg lymphocyte subpopulations and to correlate the results with the presence of the CD8+ cytotoxic T-cell (Tc) lymphocyte population. Materials and Methods: Sixty primary skin SCC specimens were incubated with anti-CD8 (clone SP57) rabbit monoclonal antibody and anti-CD25 (clone 4C9) mouse monoclonal antibody. Results: The ratio of the intratumoral/peritumoral CD4+ CD25+ forkhead box protein p3 (Foxp3) lymphocytes was 0.46, emphasizing that at tumor margins, where tumor aggressiveness is higher, these lymphocytes subpopulations facilitate tumor progression. The comparative analysis of the tumor microenvironment profile revealed that in the case of intratumoral immune response, the number of Tc-type lymphocytes (CD8+) was 3.34 times higher compared to Treg lymphocytes (p<0001). In the peritumoral area, the number of Tc lymphocytes was 5.05 times higher compared to Treg lymphocytes (p<0001). Conclusions: Treg lymphocytes inhibition may cause the suppression of the antitumoral cell immune response in the tumor environment. We believe that Treg lymphocytes should represent a focus of interest for a new personalized therapy. New studies are needed to better understand the immune response in the tumor microenvironment. |
format | Online Article Text |
id | pubmed-8597358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest |
record_format | MEDLINE/PubMed |
spelling | pubmed-85973582021-12-01 CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma Paşcalău, Andrei Vasile Cheregi, Cornel Dragoş Mureşan, Mihai Ştefan Şandor, Mircea Ioan Huniadi, Carmen Anca Nikin, Zoran Judea Pusta, Claudia Teodora Bodog, Florian Dorel Ionescu, Călin Pop, Ovidiu Laurean Rom J Morphol Embryol Original Paper Introduction: Squamous cell carcinoma (SCC) is the most common skin cancer with a high rate of death. Different lymphocyte populations play an important role in modulating the immune response in the tumor microenvironment. The increase in the proportion of cluster of differentiation (CD)4+ CD25+ regulatory T-cell (Treg) lymphocytes is associated, in different studies, with the increase of the cell multiplication rate. Aim: To analyze the Treg lymphocyte subpopulations and to correlate the results with the presence of the CD8+ cytotoxic T-cell (Tc) lymphocyte population. Materials and Methods: Sixty primary skin SCC specimens were incubated with anti-CD8 (clone SP57) rabbit monoclonal antibody and anti-CD25 (clone 4C9) mouse monoclonal antibody. Results: The ratio of the intratumoral/peritumoral CD4+ CD25+ forkhead box protein p3 (Foxp3) lymphocytes was 0.46, emphasizing that at tumor margins, where tumor aggressiveness is higher, these lymphocytes subpopulations facilitate tumor progression. The comparative analysis of the tumor microenvironment profile revealed that in the case of intratumoral immune response, the number of Tc-type lymphocytes (CD8+) was 3.34 times higher compared to Treg lymphocytes (p<0001). In the peritumoral area, the number of Tc lymphocytes was 5.05 times higher compared to Treg lymphocytes (p<0001). Conclusions: Treg lymphocytes inhibition may cause the suppression of the antitumoral cell immune response in the tumor environment. We believe that Treg lymphocytes should represent a focus of interest for a new personalized therapy. New studies are needed to better understand the immune response in the tumor microenvironment. Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2021 2021-09-07 /pmc/articles/PMC8597358/ /pubmed/34609428 http://dx.doi.org/10.47162/RJME.62.1.25 Text en Copyright © 2020, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited. |
spellingShingle | Original Paper Paşcalău, Andrei Vasile Cheregi, Cornel Dragoş Mureşan, Mihai Ştefan Şandor, Mircea Ioan Huniadi, Carmen Anca Nikin, Zoran Judea Pusta, Claudia Teodora Bodog, Florian Dorel Ionescu, Călin Pop, Ovidiu Laurean CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma |
title | CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma |
title_full | CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma |
title_fullStr | CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma |
title_full_unstemmed | CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma |
title_short | CD4+ CD25+ regulatory T-cells role in tumor microenvironment of the squamous cell carcinoma |
title_sort | cd4+ cd25+ regulatory t-cells role in tumor microenvironment of the squamous cell carcinoma |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597358/ https://www.ncbi.nlm.nih.gov/pubmed/34609428 http://dx.doi.org/10.47162/RJME.62.1.25 |
work_keys_str_mv | AT pascalauandreivasile cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT cheregicorneldragos cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT muresanmihaistefan cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT sandormirceaioan cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT huniadicarmenanca cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT nikinzoran cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT judeapustaclaudiateodora cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT bodogfloriandorel cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT ionescucalin cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma AT popovidiulaurean cd4cd25regulatorytcellsroleintumormicroenvironmentofthesquamouscellcarcinoma |